quinidine has been researched along with bupivacaine in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (22.73) | 18.7374 |
| 1990's | 2 (9.09) | 18.2507 |
| 2000's | 7 (31.82) | 29.6817 |
| 2010's | 8 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bedoya, M; Decher, N; González, W; Kiper, AK; Ramírez, D; Rinné, S | 1 |
| Clarkson, CW; Hondeghem, LM | 1 |
| Wood, M | 1 |
| Ghoneim, MM; Pandya, H | 1 |
| Lalka, D; McNamara, PJ; Pieper, JA; Slaughter, RL; Wyman, MG | 1 |
| Chemtob, S; Deng, XF; Mulay, S; Varma, DR | 1 |
| Chavez, RA; Forsayeth, JR; Gray, AT; Harada, M; Kindler, CH; Leonoudakis, D; Taylor, DM; Winegar, BD; Yost, CS | 1 |
| Buckler, KJ; Honore, E; Williams, BA | 1 |
| Arias, C; Caballero, R; Delpón, E; González, T; Moreno, I; Navarro-Polanco, R; Tamargo, J; Tamkun, MM; Valenzuela, C | 1 |
| Asada, A; Funao, T; Oda, Y; Tanaka, K | 1 |
| Chen, YW; Cheng, KI; Chu, CC; Chu, KS; Huang, KL; Tzeng, JI; Wang, JJ | 1 |
| Cohen, NA; Kreindler, JL; Wilber, M; Xiong, G; Zhao, KQ | 1 |
| Chen, YC; Chen, YW; Chu, CC; Leung, YM; Wang, JJ | 1 |
| Breton, JD; Stuart, GJ | 1 |
2 review(s) available for quinidine and bupivacaine
| Article | Year |
|---|---|
TASK Channels Pharmacology: New Challenges in Drug Design.
Topics: Animals; Drug Design; Drug Discovery; Humans; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Tandem Pore Domain | 2019 |
Plasma drug binding: implications for anesthesiologists.
Topics: Age Factors; Alfentanil; Alprenolol; Anesthesia; Anesthetics; Blood Proteins; Bupivacaine; Burns; Cardiac Surgical Procedures; Chlorpromazine; Dipyridamole; Disopyramide; Etidocaine; Female; Fentanyl; Half-Life; Humans; Imipramine; Kidney Diseases; Lidocaine; Liver; Mathematics; Meperidine; Methadone; Myocardial Infarction; Orosomucoid; Prazosin; Pregnancy; Propranolol; Protein Binding; Quinidine; Serum Albumin; Sex Factors | 1986 |
20 other study(ies) available for quinidine and bupivacaine
| Article | Year |
|---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Evidence for a specific receptor site for lidocaine, quinidine, and bupivacaine associated with cardiac sodium channels in guinea pig ventricular myocardium.
Topics: Animals; Bupivacaine; Dose-Response Relationship, Drug; Drug Interactions; Female; Guinea Pigs; In Vitro Techniques; Ion Channels; Kinetics; Lidocaine; Male; Membrane Potentials; Models, Biological; Myocardial Contraction; Myocardium; Papillary Muscles; Quinidine; Receptors, Drug | 1985 |
Plasma protein binding of bupivacaine and its interaction with other drugs in man.
Topics: Atropine; Binding, Competitive; Blood Proteins; Bupivacaine; Desipramine; Dialysis; Drug Interactions; Heparin; Humans; Meperidine; Phenytoin; Protein Binding; Quinidine | 1974 |
Factors influencing serum protein binding of lidocaine in humans.
Topics: Acecainide; Blood Proteins; Bupivacaine; Disopyramide; Humans; Lidocaine; Orosomucoid; Procainamide; Propranolol; Protein Binding; Quinidine; Serum Albumin | 1981 |
Mechanisms of the atrium-specific positive inotropic activities of quinidine- and atropine-like agents in rats.
Topics: Animals; Anti-Arrhythmia Agents; Atropine; Bupivacaine; Catecholamines; Dimethylphenylpiperazinium Iodide; Disopyramide; Heart Atria; Isoproterenol; Male; Myocardial Contraction; Propranolol; Quinidine; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Stimulation, Chemical | 1997 |
An open rectifier potassium channel with two pore domains in tandem cloned from rat cerebellum.
Topics: Acids; Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Barium; Blotting, Northern; Bupivacaine; Central Nervous System Depressants; Cerebellum; Cloning, Molecular; Ethanol; Ion Channel Gating; Lidocaine; Magnesium; Molecular Sequence Data; Oocytes; Patch-Clamp Techniques; Peptides; Phenytoin; Phosphorylation; Potassium Channels; Quinidine; Rats; RNA, Messenger; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Tetraethylammonium; Xenopus; Zinc | 1998 |
An oxygen-, acid- and anaesthetic-sensitive TASK-like background potassium channel in rat arterial chemoreceptor cells.
Topics: Acidosis; Anesthetics; Animals; Barium; Bupivacaine; Carotid Arteries; Cells, Cultured; Chemoreceptor Cells; Halothane; Hydrogen-Ion Concentration; In Situ Hybridization; Nerve Tissue Proteins; Oxygen; Patch-Clamp Techniques; Potassium Channels; Potassium Channels, Tandem Pore Domain; Quinidine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Zinc | 2000 |
Assembly with the Kvbeta1.3 subunit modulates drug block of hKv1.5 channels.
Topics: Anesthetics, Local; Bupivacaine; Cells, Cultured; Electrophysiology; Humans; Kv1.3 Potassium Channel; Kv1.5 Potassium Channel; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quinidine; Transfection | 2002 |
The P-glycoprotein inhibitor quinidine decreases the threshold for bupivacaine-induced, but not lidocaine-induced, convulsions in rats.
Topics: Anesthetics, Local; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Gas Analysis; Brain; Bupivacaine; Chromatography, High Pressure Liquid; Hemodynamics; Hydrogen-Ion Concentration; Lidocaine; Male; Quinidine; Rats; Rats, Sprague-Dawley; Seizures | 2003 |
The cutaneous analgesic effect of class I antiarrhythmic drugs.
Topics: Analgesics; Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Bupivacaine; Dose-Response Relationship, Drug; Flecainide; Injections, Subcutaneous; Lidocaine; Male; Mexiletine; Pain Measurement; Pain Threshold; Quinidine; Rats; Rats, Sprague-Dawley; Reflex; Skin; Sodium Channel Blockers; Time Factors | 2007 |
A role for two-pore K⁺ channels in modulating Na⁺ absorption and Cl⁻ secretion in normal human bronchial epithelial cells.
Topics: Absorption; Amiloride; Bronchi; Bupivacaine; Cell Line; Cell Polarity; Chlorides; Colforsin; Epithelial Cells; Humans; Immunohistochemistry; Ion Transport; Potassium Channel Blockers; Potassium Channels, Tandem Pore Domain; Quinidine; Respiratory Mucosa; Sodium | 2012 |
Spinal blockades of class I antiarrythmic drugs with bupivacaine by isobolographic analysis in rats.
Topics: Anesthesia, Spinal; Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Bupivacaine; Dose-Response Relationship, Drug; Flecainide; Injections, Spinal; Male; Mexiletine; Quinidine; Rats; Rats, Sprague-Dawley | 2012 |
GABA
Topics: Animals; Bee Venoms; Bupivacaine; CA1 Region, Hippocampal; Female; G Protein-Coupled Inwardly-Rectifying Potassium Channels; GABA-B Receptor Antagonists; Male; Neocortex; Potassium Channel Blockers; Pyramidal Cells; Quinidine; Rats; Rats, Wistar; Receptors, GABA-B | 2017 |